SCOR (SCR) Investor Day 2024 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2024 summary
11 Jan, 2026Strategic plan, direction, and organizational transformation
Forward 2026 strategy targets 9% annual Economic Value growth and ROE above 12% for 2025-2026, leveraging a tier-one franchise for diversified, sustainable growth and operational modernization.
Organizational restructuring reduced management layers and headcount, improving agility, client proximity, and decision-making speed.
Group transformation and simplification initiatives are delivering €150 million in savings nearly one year ahead of plan, with an additional €30 million in Life & Health, supporting profitability and reinvestment in growth.
Capital allocation is now dynamically steered by business line, aiming for a balanced, lower capital intensity portfolio and optimizing returns.
Governance and management structures have been strengthened to support execution and operational efficiency.
Life & Health (L&H) business strategy and financial outlook
L&H business mix is shifting from over 90% traditional protection to higher-margin, capital-efficient Longevity and Financial Solutions, targeting improved ROE by 2-3% and new business profitability by 2026.
Exited low-margin or high-volatility markets, centralized operations, and set minimum margin thresholds for new business.
L&H new business CSM and insurance service result both targeted at ~€0.4 billion per annum for 2025-2026, with CSM growth of 1%-3% p.a. and amortization rate revised down to 6.5%.
In-force management is centralized, with enhanced data analytics, KPIs, and leadership incentives to protect and deliver value.
Life & Health cash flow break-even delayed to 2026, with cash flow generation a top priority for new leadership.
Property & Casualty (P&C) business performance and outlook
P&C strategy focuses on portfolio diversification, growth in attractive lines (marine, engineering, international casualty), and prudent climate risk management.
Exceeded Forward 2026 targets ahead of schedule, with significant growth in diversified and alternative solutions lines; EGPI for Alternative Solutions nearly doubled and is targeted to triple by 2026.
Maintained strong underwriting discipline, with Cat portfolio managed within a 10% ratio and net combined ratio below 87%.
Insurance revenue growth of 4-6% annually expected for 2024-2026, with double-digit EGPI growth in 2025.
Market conditions remain favorable, supporting expansion in Construction and Energy lines to address global infrastructure and transition needs.
Latest events from SCOR
- FY net income up to EUR 851M, ROE above 19%, dividend EUR 1.9/share, solvency 215%.SCR
Q4 20254 Mar 2026 - Q2 2024 net loss driven by L&H review, but P&C and solvency remain strong.SCR
Q2 202410 Feb 2026 - H1 2025 net income EUR 425m, ROE 20.3%, P&C combined ratio 82.5%, solvency 210%.SCR
Q2 202510 Feb 2026 - January 2026 renewals drove 14.8% EGPI growth and improved underwriting in a competitive market.SCR
Investor update4 Feb 2026 - Strong P&C and investment results offset by L&H review, solvency robust at 203%.SCR
Q3 202414 Jan 2026 - 9.6% EGPI growth driven by Specialty and Alternative Solutions, with stable profitability.SCR
Investor Update9 Jan 2026 - Q4 2024 net income EUR 233m, adjusted FY net income EUR 728m, solvency at 210%, dividend EUR 1.8.SCR
Q4 202413 Dec 2025 - Q1 2025 net income hit EUR 200m, with robust solvency and strong segment performance.SCR
Q1 202518 Nov 2025 - Q3 2025 delivered EUR 217m net income, 21.5%–22.1% ROE, and a 210% solvency ratio.SCR
Q3 20252 Nov 2025